Cargando…
Personalizing treatment selection in Crohn’s disease: a meta-analysis of individual participant data from fifteen randomized controlled trials
BACKGROUND: Meta-analyses have found anti-TNF drugs to be the best treatment, on average, for Crohn’s disease. We performed a subgroup analysis to determine if it is possible to achieve more efficacious outcomes by individualizing treatment selection. METHODS: We obtained participant-level data from...
Autores principales: | Rudrapatna, Vivek A., Ravindranath, Vignesh G., Arneson, Douglas V., Mosenia, Arman, Butte, Atul J., Wang, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659518/ https://www.ncbi.nlm.nih.gov/pubmed/37986977 http://dx.doi.org/10.1101/2023.11.10.23291837 |
Ejemplares similares
-
Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group
por: Rudrapatna, Vivek A., et al.
Publicado: (2023) -
CovidCounties - an interactive, real-time tracker of the COVID-19 pandemic at the level of US counties
por: Arneson, Douglas, et al.
Publicado: (2020) -
CovidCounties is an interactive real time tracker of the COVID19 pandemic at the level of US counties
por: Arneson, Douglas, et al.
Publicado: (2020) -
Creation of an ustekinumab external control arm for Crohn’s disease using electronic health records data: A pilot study
por: Rudrapatna, Vivek A., et al.
Publicado: (2023) -
Utility of routinely collected electronic health records data to support effectiveness evaluations in inflammatory bowel disease: a pilot study of tofacitinib
por: Rudrapatna, Vivek Ashok, et al.
Publicado: (2021)